10월 4, 2021 Certara Senior Scientific Leader Receives 2021 Leadership Award by International Society of Pharmacometrics
9월 30, 2021 Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
9월 20, 2021 Certara는 바이오시뮬레이션을 사용하여 제네릭 의약품의 가상 생물학적 동등성 평가를 더욱 발전시키기 위해 FDA(Food and Drug Administration) 보조금을 받았습니다.
9월 13, 2021 Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares